1. Apoptosis Autophagy Metabolic Enzyme/Protease
  2. Caspase Autophagy Endogenous Metabolite
  3. Crustecdysone

Crustecdysone  (Synonyms: 20-Hydroxyecdysone)

Cat. No.: HY-N6979 Purity: 99.20%
Handling Instructions Technical Support

Crustecdysone (20-Hydroxyecdysone) is a naturally occurring ecdysteroid hormone isolated from Serratula coronata which controls the ecdysis (moulting) and metamorphosis of arthropods, it inhibits caspase activity and induces autophagy via the 20E nuclear receptor complex, EcR-USP. Crustecdysone exhibits regulatory or protective roles in the cardiovascular system. Crustecdysone is an active metabolite of Ecdysone (HY-N0179).

For research use only. We do not sell to patients.

CAS No. : 5289-74-7

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 11 publication(s) in Google Scholar

Other Forms of Crustecdysone:

Top Publications Citing Use of Products

    Crustecdysone purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2024 Dec 3;25(23):12976.  [Abstract]

    The effects of Crustecdysone (20E: 5 μg) treatment on diapause rate, expression level of diapause-related genes.

    Crustecdysone purchased from MedChemExpress. Usage Cited in: Transl Oncol. 2024 Jul:45:101958.  [Abstract]

    Several bladder cancer cell lines (J82, 5637, T24, UMUC3 and SW780) and normal human urothelial cell line (SV-HUC-1) were incubated with different concentrations (from 0 to 100 μM) of 20-HE for 24 h. Then, all cells were collected for cell viability calculation using CCK-8 analysis.

    Crustecdysone purchased from MedChemExpress. Usage Cited in: Transl Oncol. 2024 Jul:45:101958.  [Abstract]

    Bladder cancer cell lines T24 and UMUC3 were incubated with Crustecdysone (20-HE: 2.5, 5, or 10 μM). After 24 hours of treatment, apoptosis in the bladder cancer cells was analyzed by flow cytometry.

    Crustecdysone purchased from MedChemExpress. Usage Cited in: Transl Oncol. 2024 Jul:45:101958.  [Abstract]

    Bladder cancer cell lines T24 and UMUC3 were incubated with Crustecdysone (20-HE: 2.5, 5, or 10 μM). After 24 hours of treatment, the expression level of Bcl-2 mRNA was analyzed by RT-qPCR.

    Crustecdysone purchased from MedChemExpress. Usage Cited in: Transl Oncol. 2024 Jul:45:101958.  [Abstract]

    Bladder cancer cell lines T24 and UMUC3 were incubated with Crustecdysone (20-HE: 2.5, 5, or 10 μM). After 24 hours of treatment, Western blot analysis was performed to determine the expression level of cleaved Caspase-3 protein.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Crustecdysone (20-Hydroxyecdysone) is a naturally occurring ecdysteroid hormone isolated from Serratula coronata which controls the ecdysis (moulting) and metamorphosis of arthropods, it inhibits caspase activity and induces autophagy via the 20E nuclear receptor complex, EcR-USP[1]. Crustecdysone exhibits regulatory or protective roles in the cardiovascular system[2]. Crustecdysone is an active metabolite of Ecdysone (HY-N0179)[3].

    Cellular Effect
    Cell Line Type Value Description References
    Huh-7 CC50
    > 700 μM
    Compound: 4
    Cytotoxicity against human HuH7 cells assessed as reduction in cell viability after 72 hrs by MTS assay
    Cytotoxicity against human HuH7 cells assessed as reduction in cell viability after 72 hrs by MTS assay
    [PMID: 26988299]
    Huh-7 EC50
    53.55 μM
    Compound: 4
    Antiviral activity against Dengue virus 2 DN454009A infected in human HuH7 cells assessed as inhibition of viral RNA level measured 72 hrs post infection by qRT-PCR method
    Antiviral activity against Dengue virus 2 DN454009A infected in human HuH7 cells assessed as inhibition of viral RNA level measured 72 hrs post infection by qRT-PCR method
    [PMID: 26988299]
    In Vitro

    Crustecdysone induces cell autophagy and caspase-3 activity in the remodeling fat body of Drosophila[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Crustecdysone (5 or 10 mg/kg; i.p., once daily, for 6 weeks) reduces blood pressure and prevents dilated cardiac hypertrophy in SHR rats[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Male spontaneous hypertensive (SHR) rats[2]
    Dosage: 5 or 10 mg/kg
    Administration: Intraperitoneal injection; 5 or 10 mg/kg , once daily, for 6 weeks
    Result: Decreased seminal vesicular weight, systolic pressure, and left ventricular dilatation caused by hypertension. Increased testicular weight and amount of β-isoform.
    Clinical Trial
    Molecular Weight

    480.63

    Formula

    C27H44O7

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O[C@@H]1[C@H](O)C[C@](C(C=C2[C@]3([H])CC[C@@]4(C)[C@@]2(O)CC[C@]4([H])[C@](O)(C)[C@H](O)CCC(O)(C)C)=O)([H])[C@]3(C)C1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, protect from light

    *In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (208.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 8.33 mg/mL (17.33 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.0806 mL 10.4030 mL 20.8060 mL
    5 mM 0.4161 mL 2.0806 mL 4.1612 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (4.33 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (4.33 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.23%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 2.0806 mL 10.4030 mL 20.8060 mL 52.0151 mL
    5 mM 0.4161 mL 2.0806 mL 4.1612 mL 10.4030 mL
    10 mM 0.2081 mL 1.0403 mL 2.0806 mL 5.2015 mL
    15 mM 0.1387 mL 0.6935 mL 1.3871 mL 3.4677 mL
    DMSO 20 mM 0.1040 mL 0.5202 mL 1.0403 mL 2.6008 mL
    25 mM 0.0832 mL 0.4161 mL 0.8322 mL 2.0806 mL
    30 mM 0.0694 mL 0.3468 mL 0.6935 mL 1.7338 mL
    40 mM 0.0520 mL 0.2601 mL 0.5202 mL 1.3004 mL
    50 mM 0.0416 mL 0.2081 mL 0.4161 mL 1.0403 mL
    60 mM 0.0347 mL 0.1734 mL 0.3468 mL 0.8669 mL
    80 mM 0.0260 mL 0.1300 mL 0.2601 mL 0.6502 mL
    100 mM 0.0208 mL 0.1040 mL 0.2081 mL 0.5202 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Crustecdysone
    Cat. No.:
    HY-N6979
    Quantity:
    MCE Japan Authorized Agent: